About the doctor
The clinic where the doctor is located
More detail about the doctor
2019-2022
Istanbul Medipol Mega University Hospital Oncology yandal
2019-2022
Istanbul Medipol Mega University Hospital Oncology Department
2014-2019
Istanbul University Istanbul Faculty of Medicine Internal Medicine Specialist
2004-2010
Azerbaijan Medical University
No certificate found for this doctor.
Turkish Medical Oncology Society
ESMO: European oncology society
ASCO: American Oncology Society
A randomized, double-blind, phase 3 study of platinum-based chemotherapy with or without INCMGA00012 in first-line metastatic squamous and non-squamous non-small cell lung cancer with or without INCMGA00012
A Phase III, Double-Blind, Placebo-Controlled Randomized Trial Evaluating the Combination of Ipatasertib. Atezolizumab and Paclitaxel in Patients with Locally Advanced Unresectable or Metastatic Triple-Negative Breast Cancer (C041101 IPATUNITY 170 MINISTRY CODE: 19-ROC-05)
A Randomized, Open-Label Phase 3 Study Comparing Amivantamab and Carboplatin Pemetrexet Combination Therapy with Carboplatin Pemetrexet Therapy in Locally Advanced or Metastatic Non-Small Cell Lung Cancer Patients with an EGFR Exon 20ins Mutation was titled ”and “61186372NSC3001 (Ministry code: 202003118)
Procedures performed by M.D. Elxan Memmedov
Get free consultation
M.D. Elxan Memmedov
Ask us any question you might have
M.D. Elxan Memmedov
Get Free Consultation
How it works:
